Founded by Genzyme Alumni, Cambridge's X4 Pharma Scores $27M Post author:Sam Post published:November 15, 2017 Post category:BioPharma X4 Pharma announced it had closed a $27M Series B financing. Source: BioSpace You Might Also Like Denali Therapeutics Adds $155 Million from Takeda March 18, 2018 Forensic Exam Shows Pattern in 4 Deaths of Sanofi Dengue Vaccine Recipients January 9, 2018 Senti Biosciences Raises $53 Million from Amgen and Others in Series A Financing February 26, 2018
